APA (7th ed.) Citation

P, R., J, G. P., Y, L., J, D., NWCJ, v. d. D., XL, M., . . . BD, S. (2026). Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies. Clinical lymphoma, myeloma & leukemia, 26(7), 423. https://doi.org/10.1016/j.clml.2026.04.013

Chicago Style (17th ed.) Citation

P, Rodríguez-Otero, et al. "Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies." Clinical Lymphoma, Myeloma & Leukemia 26, no. 7 (2026): 423. https://doi.org/10.1016/j.clml.2026.04.013.

MLA (9th ed.) Citation

P, Rodríguez-Otero, et al. "Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies." Clinical Lymphoma, Myeloma & Leukemia, vol. 26, no. 7, 2026, p. 423, https://doi.org/10.1016/j.clml.2026.04.013.